Neuren Pharmaceuticals Limited's market cap is currently $2.62B. The company's EPS TTM is AU$0.119; its P/E ratio is 17.77; Neuren Pharmaceuticals Limited is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is AU$0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in AUD
Neuren Pharmaceuticals Limited Earnings and Revenue History
